<?xml version="1.0" encoding="UTF-8"?>
<p>Twenty-one drugs with &gt;20% CPE inhibitions, identified during the first round of screening, were used for the second round of screening. The drug name, catalogue number of Selleck, and the final percentage CPE inhibition of the 21 drugs are listed in 
 <xref ref-type="app" rid="app1-viruses-11-00742">Table S1</xref>, and the inhibitory effects of these drugs, when these drugs were added 1 h post-virus infection are also listed in 
 <xref ref-type="app" rid="app1-viruses-11-00742">Table S1</xref>. Seven drugs with percentage CPE inhibitions &gt;50% were selected for further CC
 <sub>50</sub> and EC
 <sub>50</sub> assays, and the results are shown in 
 <xref ref-type="fig" rid="viruses-11-00742-f002">Figure 2</xref> and 
 <xref ref-type="app" rid="app1-viruses-11-00742">Figure S1</xref> and are also listed in 
 <xref rid="viruses-11-00742-t001" ref-type="table">Table 1</xref>.
</p>
